Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol versus gadoteridol: A pilot study

PURPOSE: We evaluated dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging (DSC-MRI) using gadoteridol in comparison to the iron oxide nanoparticle blood pool agent, ferumoxytol in patients with glioblastoma multiforme (GBM) who received standard radiochemotherapy (RCT). METH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gahramanov, Seymur, Raslan, Ahmed, Muldoon, Leslie L., Hamilton, Bronwyn E., Rooney, William D., Varallyay, Csanad G., Njus, Jeffrey M., Haluska, Marianne, Neuwelt, Edward A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3111452/
https://ncbi.nlm.nih.gov/pubmed/20395065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2009.10.072
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge